CTRI/2022/06/043459
Recruiting
未知
Prospective , single center interventional study to assess the effect of spiritual therapy in the treatment of autistic children
Bhaktivedanta Hospital and Research Institute0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
- Sponsor
- Bhaktivedanta Hospital and Research Institute
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Any child aged 2 to 18 years, diagnosed Autism spectrum disorder by DSM\- 5 criteria with severity grading done using CARS score will be enrolled.
Exclusion Criteria
- •1\. Children with autism with developmental delay will be excluded.
- •2\. The cases which fulfills DSM\-5 criteria of ASD incompletely.
- •3\. Autistic children with hearing defect.
- •4\. Children with major chromosomal defect or with neuro\-structural defect.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A study to check effect of an Ayurvedic treatment on corona positive patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/07/026601Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai61
Completed
Phase 4
Prospective, single-center, interventional follow-up study to determine the effect of prostate carcinoma and its operative therapy on intraocular pressure and determination of potential mediators.prostate cancer, mamma carcinoma, colorectal carcinomaH40.1Primary open-angle glaucomaDRKS00015830Diakonie Klinikum Dietrich Bonhoeffer GmbH76
Not yet recruiting
Phase 4
A Study to Investigate the Switch from Thyronorm or Eltroxin Tablet to Lethyrox Tablet in Patients withPrimary Hypothyroidism.Health Condition 1: E039- Hypothyroidism, unspecifiedCTRI/2022/05/042396Intas Pharmaceuticals Ltd
Recruiting
Not Applicable
on-interventional, prospective, multicenter study to evaluate treatment satisfaction, treatment preference, quality of life, and tolerability under treatment with Briumvi® for relapsing forms of multiple sclerosis (RMS) with active disease in daily clinical practiceG35Multiple sclerosisDRKS00034406euraxpharm Pharmaceuticals, S.L.600
Recruiting
Not Applicable
To assess the efficacy and applicability of a single injection of Erector spinae plane in video assisted thoracoscopic surgeriesCTRI/2019/05/019413TATA MEMORIAL CENTRE